Home > Financial Ratios > CORONA REMEDIES

CORONA REMEDIES
EBIT Margin

    Back to All Ratios
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year EBIT Margin History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
   EBIT Margin(%) 17.9317.8012.8212.82

What is the latest EBIT Margin ratio of CORONA REMEDIES ?

The latest EBIT Margin ratio of CORONA REMEDIES is 17.93 based on Mar2026 Consolidated results.
Year EBIT Margin
Mar202617.93
Mar202517.80
Mar202412.82
Mar202312.82

How is EBIT Margin of CORONA REMEDIES Trending?

Years EBIT Margin % Change
Mar2026 17.93
0.73
Mar2025 17.8
38.85
Mar2024 12.82
0.00
Mar2023 12.82 -

Other Financial Ratios of CORONA REMEDIES


Compare EBIT Margin ratio of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹12,483.9 Cr -2.6% -2.9% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹427,861.0 Cr -2% -6.1% 12.9% Stock Analytics
DIVIS LABORATORIES ₹254,319.0 Cr 3.2% 5.3% 67.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,153.0 Cr -1.9% -2.9% 32.7% Stock Analytics
CIPLA ₹107,406.0 Cr -1.5% -4% -10.6% Stock Analytics
DR REDDYS LABORATORIES ₹100,362.0 Cr -2.7% 4.2% -1.2% Stock Analytics


CORONA REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-2.6%

-2.9%

NA
SENSEX

0.2%

-4.6%

-9.6%


You may also like the below Video Courses